A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants

Part of paid clinical trials in Miami, Florida.

Sponsor
Bristol-Myers Squibb
Study ID
NCT07226817
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Healthy Volunteers

Eligibility Criteria

Sex
ALL
Age
18 Years - 60 Years
Healthy Volunteers
Accepted

Interventions

  • BMS-986435 — DRUG
    Specified dose on specified days

Study Details

This study is designed to evaluate the relative bioavailability (rBA) of multiple test tablet formulations of BMS-986435 compared to an equal dose of the BMS-986435 reference tablet formulation. The effect of food on the selected BMS-986435 tablet formulation will also be evaluated.

Key Dates

Start date
Nov 12, 2025
Status verified
Mar 2026
Primary completion
Jul 1, 2026
Completion
Jul 1, 2026

Study Design

Enrollment
140 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment A
  • Experimental: Treatment B
  • Experimental: Treatment C
  • Experimental: Treatment D
  • Experimental: Treatment E
  • Experimental: Treatment F
  • Experimental: Treatment G

Primary Outcome Measure

Maximum observed concentration (Cmax) [ Time Frame: Up to Day 28 ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.

Locations (1)

FacilityCityStateZIPSite coordinators
Quotient MiamiMiamiFlorida33126
Juliet Vento

Find similar trials in Miami, FL

By research site
Quotient Miami· Miami, FL

Related Studies